Tumor ablation is a minimally invasive medical procedure used to destroy abnormal tissues or tumors, such as cancerous or non-cancerous growths, without the need for surgery. It is typically performed using various energy sources, including radiofrequency, microwave, laser, or ultrasound.
During a tumor ablation procedure, a small needle or probe is inserted into the tumor under guidance of imaging techniques, such as ultrasound or CT scan. The energy source is then applied to the probe, which generates heat that destroys the cancerous cells or abnormal tissues. The heat causes coagulation of the tissues and eventual necrosis, leading to the destruction of the tumor.
Request Report Sample - https://www.alliedmarketresearch.com/request-sample/17626
The
tumor ablation market size was valued at $1.3 billion in 2021, and is estimated
to reach $4.7 billion by 2031, growing at a CAGR of 13.6% from 2022 to
2031.
On the basis of technology, the other segment was the major revenue contributor in 2021, owing to increased specificity while using laser ablation surgery compared to other traditional methods. This segment includes laser ablation technology and high-intensity focused ultrasound technology. The microwave ablation segment is expected to witness lucrative growth during the forecast period, owing to advancements in imaging technology and accuracy to spot specific target cells.
On the basis of treatment, the market is classified into surgical ablation, laparoscopic ablation, and percutaneous ablation. The surgical ablation segment was the major revenue contributor in 2021, owing to an increase in the prevalence of cancer, advancements in technology, and minimum risk associated with treatment.
Procure Complete
Report (262 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/e0824c61283afc85fff6ec4cc2c98741
On the basis of
application, the liver cancer segment was the highest revenue contributor in
2021, owing to an increase in liver cancer cases and lifestyle changes.
However, the kidney cancer segment is expected to exhibit the fastest growth
during the forecast period, owing to an increase in the number of kidney cancer
cases, reduced physical activities, and excessive smoking and drinking.Some of
the key players in the tumor ablation market include
·
Abbott Laboratories,
·
AngioDynamics Inc.,
·
Bioventus (Misonix Inc.),
·
Boston Scientific Corporation,
·
ConMed Corporation,
·
Elekta Inc.,
·
Galil Medical Inc.,
·
HealthTronics Inc.,
·
Johnson & Johnson,
·
Medtronic Plc.
Do Inquiry before buying - https://www.alliedmarketresearch.com/purchase-enquiry/17626
Related Reports-
Surgical Glue Market - https://www.alliedmarketresearch.com/surgical-glue-market-A31580
